BG105310A - Process for the preparation of a non-crystalline anhydrate from paroxetine hydrochloride - Google Patents

Process for the preparation of a non-crystalline anhydrate from paroxetine hydrochloride

Info

Publication number: BG105310A
Authority: BG; Bulgaria
Prior art keywords: paroxetine hydrochloride; preparation; crystalline anhydrate; propan; solvate
Prior art date: 1998-08-07

Application number

BG105310A

Other languages

Bulgarian (bg)

English (en)

Inventor

Victor JACEWICZ

Neal Ward

Original Assignee

Smithkline Beecham Plc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-08-07

Filing date

2001-03-06

Publication date

2001-12-29

1998-08-07 Priority claimed from GBGB9817196.0A external-priority patent/GB9817196D0/en

1998-12-29 Priority claimed from GBGB9828777.4A external-priority patent/GB9828777D0/en

2001-03-06 Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc

2001-12-29 Publication of BG105310A publication Critical patent/BG105310A/xx

Links

AHOUBRCZNHFOSL-UHFFFAOYSA-N 3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine Chemical compound C1=CC(F)=CC=C1C1C(COC=2C=C3OCOC3=CC=2)CNCC1 AHOUBRCZNHFOSL-UHFFFAOYSA-N 0.000 title abstract 6
229960005183 paroxetine hydrochloride Drugs 0.000 title abstract 3
239000012453 solvate Substances 0.000 abstract 3
KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 abstract 2
238000010438 heat treatment Methods 0.000 abstract 2
230000007423 decrease Effects 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
Neurosurgery (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Pain & Pain Management (AREA)
Psychiatry (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)

BG105310A 1998-08-07 2001-03-06 Process for the preparation of a non-crystalline anhydrate from paroxetine hydrochloride BG105310A (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
GBGB9817196.0A GB9817196D0 (en)	1998-08-07	1998-08-07	Novel process
GBGB9828777.4A GB9828777D0 (en)	1998-12-29	1998-12-29	Novel compounds
PCT/GB1999/002592 WO2000008017A1 (en)	1998-08-07	1999-08-06	Process for the preparation of a non-crystalline anhydrate form of paroxetine hydrochloride

Publications (1)

Publication Number	Publication Date
BG105310A true BG105310A (en)	2001-12-29

Family

ID=26314179

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BG105310A BG105310A (en)	1998-08-07	2001-03-06	Process for the preparation of a non-crystalline anhydrate from paroxetine hydrochloride

Country Status (23)

Country	Link
EP (2)	EP1100796B1 (de)
JP (1)	JP2002522434A (de)
KR (1)	KR20010072323A (de)
CN (1)	CN1321155A (de)
AP (2)	AP0102072A0 (de)
AT (1)	ATE239016T1 (de)
AU (1)	AU5428999A (de)
BG (1)	BG105310A (de)
BR (1)	BR9912858A (de)
CA (1)	CA2339857A1 (de)
DE (1)	DE69907467T2 (de)
DK (1)	DK1100796T3 (de)
EA (1)	EA200100221A1 (de)
ES (1)	ES2198940T3 (de)
HU (1)	HUP0105466A3 (de)
ID (1)	ID27914A (de)
IL (1)	IL141286A0 (de)
NO (1)	NO20010629L (de)
PL (1)	PL345885A1 (de)
PT (1)	PT1100796E (de)
SK (1)	SK1972001A3 (de)
TR (1)	TR200100444T2 (de)
WO (1)	WO2000008017A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1394160A1 (de)	1996-06-13	2004-03-03	SUMIKA FINE CHEMICALS Co., Ltd.	Verfahren zur Herstellung von kristallinem Paroxetin-Hydrochlorid
JP3796351B2 (ja) *	1998-04-13	2006-07-12	住友化学株式会社	パロキセチン塩酸塩無水和物の乾燥方法
GB9923446D0 (en) *	1999-10-04	1999-12-08	Smithkline Beecham Plc	Novel process
EP1345955B1 (de) *	2000-11-17	2008-08-20	Eli Lilly And Company	Lactam dipeptid und dessen verwendung zur inhibierung der beta-amyloid peptid frisetzung
WO2004035052A1 (ja)	2002-10-16	2004-04-29	Takeda Pharmaceutical Company Limited	安定な固形製剤

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB1422263A (en) *	1973-01-30	1976-01-21	Ferrosan As	4-phenyl-piperidine compounds
EP0223403B1 (de) *	1985-10-25	1993-08-04	Beecham Group Plc	Piperidinderivat, seine Herstellung und seine Verwendung als Arzneimittel
AR001982A1 (es) *	1995-02-06	1998-01-07	Smithkline Beecham Plc	Clorhidrato de paroxetina anhidratado, y procedimiento para su preparacion
EP0952831A1 (de) *	1997-01-15	1999-11-03	Smithkline Beecham Plc	Paroxetinhaltige arzneizubereitungen
JP3796351B2 (ja) *	1998-04-13	2006-07-12	住友化学株式会社	パロキセチン塩酸塩無水和物の乾燥方法

1999
- 1999-08-06 CA CA002339857A patent/CA2339857A1/en not_active Abandoned
- 1999-08-06 DE DE69907467T patent/DE69907467T2/de not_active Expired - Fee Related
- 1999-08-06 PL PL99345885A patent/PL345885A1/xx not_active Application Discontinuation
- 1999-08-06 AU AU54289/99A patent/AU5428999A/en not_active Abandoned
- 1999-08-06 AP APAP/P/2001/002072A patent/AP0102072A0/en unknown
- 1999-08-06 AP AP2001002072A patent/AP2001002072A0/xx unknown
- 1999-08-06 EP EP99940290A patent/EP1100796B1/de not_active Expired - Lifetime
- 1999-08-06 KR KR1020017001635A patent/KR20010072323A/ko not_active Withdrawn
- 1999-08-06 EP EP02080022A patent/EP1321465A3/de not_active Withdrawn
- 1999-08-06 IL IL14128699A patent/IL141286A0/xx unknown
- 1999-08-06 WO PCT/GB1999/002592 patent/WO2000008017A1/en not_active Ceased
- 1999-08-06 JP JP2000563650A patent/JP2002522434A/ja active Pending
- 1999-08-06 CN CN99811643A patent/CN1321155A/zh active Pending
- 1999-08-06 SK SK197-2001A patent/SK1972001A3/sk unknown
- 1999-08-06 AT AT99940290T patent/ATE239016T1/de not_active IP Right Cessation
- 1999-08-06 PT PT99940290T patent/PT1100796E/pt unknown
- 1999-08-06 TR TR2001/00444T patent/TR200100444T2/xx unknown
- 1999-08-06 BR BR9912858-6A patent/BR9912858A/pt not_active Application Discontinuation
- 1999-08-06 ES ES99940290T patent/ES2198940T3/es not_active Expired - Lifetime
- 1999-08-06 ID IDW20010296A patent/ID27914A/id unknown
- 1999-08-06 HU HU0105466A patent/HUP0105466A3/hu unknown
- 1999-08-06 EA EA200100221A patent/EA200100221A1/ru unknown
- 1999-08-06 DK DK99940290T patent/DK1100796T3/da active
2001
- 2001-02-06 NO NO20010629A patent/NO20010629L/no not_active Application Discontinuation
- 2001-03-06 BG BG105310A patent/BG105310A/xx unknown

Also Published As

Publication number	Publication date
HK1038230A1 (en)	2002-03-08
ATE239016T1 (de)	2003-05-15
EA200100221A1 (ru)	2001-08-27
BR9912858A (pt)	2001-11-20
ES2198940T3 (es)	2004-02-01
WO2000008017A1 (en)	2000-02-17
DE69907467T2 (de)	2004-03-11
EP1321465A2 (de)	2003-06-25
AP2001002072A0 (en)	2001-03-31
EP1100796A1 (de)	2001-05-23
HUP0105466A3 (en)	2002-11-28
TR200100444T2 (tr)	2001-07-23
AU5428999A (en)	2000-02-28
HUP0105466A2 (hu)	2002-05-29
EP1321465A3 (de)	2003-09-03
EP1100796B1 (de)	2003-05-02
CN1321155A (zh)	2001-11-07
DE69907467D1 (de)	2003-06-05
NO20010629D0 (no)	2001-02-06
AP0102072A0 (en)	2001-02-06
PT1100796E (pt)	2003-09-30
KR20010072323A (ko)	2001-07-31
IL141286A0 (en)	2002-03-10
ID27914A (id)	2001-05-03
JP2002522434A (ja)	2002-07-23
NO20010629L (no)	2001-03-20
SK1972001A3 (en)	2001-08-06
PL345885A1 (en)	2002-01-14
CA2339857A1 (en)	2000-02-17
DK1100796T3 (da)	2003-08-25

Similar Documents

Publication	Publication Date	Title
MY119800A (en)	2005-07-29	Pyridine derivatives
GR1002466B (el)	1996-11-06	Νεες ενωσεις.
CZ258896A3 (en)	1997-03-12	Morpholine derivatives, process of their preparation and pharmaceutical compositions containing thereof
MY124151A (en)	2006-06-30	Epothilone derivatives
MX9702308A (es)	1998-04-30	Composiciones de esterol a partir de jabon de formacion de pulpa.
HUP0101511A3 (en)	2002-12-28	1-[(1-substituted-4-piperidinyl)methyl]-4-piperidine derivatives, process for producing the same, medicinal compositions containing the same and intermediates of these compounds
SI0775704T1 (en)	2001-08-31	Crystalline hydrochloride of (R)-(-)-2-(N-(4-(1,1-Dioxido-3-oxo-2,3-dihydrobenzisothiazol-2-yl)-butyl)-aminomethyl)-chroman
ATE211732T1 (de)	2002-01-15	N-benzylpiperidin- und tetrahydropyridin-derivate
HUP0100760A3 (en)	2002-12-28	2-arylethyl-(piperidin-4-ylmethyl)amine derivatives, process for producing them and pharmaceutical compositions containing them
HUP9903417A2 (hu)	2000-04-28	Új üvegösszetétel alkalmazása fogtechnikai üvegpillérek és támpillérek előállítására és eljárás az üvegpillérek előállítására
BG105310A (en)	2001-12-29	Process for the preparation of a non-crystalline anhydrate from paroxetine hydrochloride
MY125975A (en)	2006-09-29	Crystalline form vii of cabergoline
MY120550A (en)	2005-11-30	Substituted 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocin-10-ols, processes for preparing them and their use as pharmaceutical compositions.
ZA962059B (en)	1996-12-31	Control of expansion in concrete due to alkali silica reaction
BG105204A (en)	2001-11-30	Salts of paroxetine
NZ505200A (en)	2002-09-27	Carboxyl substituted chroman derivatives useful as beta 3 adrenoreceptor agonists
NZ332545A (de)	2000-01-28
PL344994A1 (en)	2001-11-19	Derivatives of 3-(2-oxo-[1,3']bipyrrolidinyl-3-ylidenemethyl)-cephems
ZA200005110B (en)	2001-05-22	Process for preparing intermediates.
BG104604A (en)	2001-03-30	Process for the preparation of paroxetin hydrochloride
TW344650B (en)	1998-11-11	Fungicidal compositions and the process for the preparation thereof
ATE262516T1 (de)	2004-04-15	Kristallines (-)-3r,4r-trans-7-methoxy-2,2-
NO20012028L (no)	2001-04-25	Fremgangsmåte for fremstilling av 4-((2',5'-diamino-6'- halogenpyrimidin-4'-yl)amino)-cyclopent-2-enyl-metanoler
AU2000246281A1 (en)	2001-11-20	Piperidine compounds and process for providing such
AU7025800A (en)	2001-04-10	Process for the preparation of 1-methyl-3-carbomethoxy-4-(4'-fluorophenyl)-piperidine